UAE's ADGM to sign MOU with Israel's securities authority on fintech    Russia says it thwarted Islamic State attacks in Moscow region, detains one: RIA    Youthful Barca take care of Dynamo to seal knockout place    PSG revive Champions League chances with Neymar penalty    Cairo collision    Akhenaten performance at the Cairo Opera House is a must go    An advisory chamber    Golden opportunities    GERD: A point of order?    Leapfrogging the transport network    Keeping up with Covid-19    Steps towards Pan-Africanism    The Egyptian Oedipus    In their footsteps    Sarwa Capital participates in The Egypt Entrepreneurship Summit in Aswan    Cairo International Book Fair suspended for five months over coronavirus concerns    Egyptian Exchange leads COMESA in attracting foreign investments    Orascom-Mitsubishi consortium signs $800m contract for Cairo Metro Line 4    Japan can host Olympics despite virus spike: Tokyo governor    Ethiopia says 'large number' of Tigrayan fighters surrender    Biden transition gets govt OK after Trump out of options    AstraZeneca novel COVID-19 vaccine can be 90% effective, results show    Polling stations open at home for 1st stage of Egyptian parliamentary run-offs    Egypt confirms 358 new coronavirus cases, 14 deaths on Saturday    G20 to discuss post-pandemic world, back debt relief    US will reduce number of its troop in Iraq, Afghanistan    Asia forms world's biggest trade bloc, a China-backed group excluding U.S    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Palestinians mourn the loss their longtime spokesman, Saeb Erekat    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    1st stage of Egypt's parliamentary elections kicks off on Saturday    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    Legend footballer Lionel Messi says he is forced to stay with Barcelona    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Iraqi conglomerate eyes developing land that housed Mubarak-era ruling party HQ    Legend Messi officially wants to leave Barcelona, hands transfer request    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





WHO hails 'triumph' as Ebola vaccine gets European green light
Published in Ahram Online on 20 - 10 - 2019

The vaccine, developed by U.S. drugmaker Merck & Co, is already being used under emergency guidelines to try to protect people against the spread of a deadly Ebola outbreak in Democratic Republic of Congo.
It protects against the Zaire strain of the Ebola virus - the one that most commonly causes outbreaks.
The shot is also being reviewed under a fast-track system by regulators in the United States, with a decision expected in the first quarter of next year.
“This vaccine has already saved many lives in the current Ebola outbreak, and the decision by European regulators will help it to eventually save many more,” the WHO's director-general Tedros Adhanom Ghebreyesus said in a statement.
The Congo Ebola outbreak has killed more than 2,100 people since the middle of last year. It is the second-largest Ebola outbreak in history, after a 2013-16 epidemic in West Africa that killed more than 11,300.

The Merck vaccine, which the company has now brand-named Ervebo, is likely to get a full marketing license from the European Commission in a few weeks.
Roger Perlmutter, president of Merck Research Laboratories, said the company's priority now was to get regulatory approval of its Ervebo manufacturing site in Germany so that licensed supply of the vaccine “can be used to support global public health preparedness”.
Merck's vaccine is being used in Congo in a so-called “ring vaccination” approach, in which people who may have been in contact with someone newly infected with Ebola are traced and offered the shot to protect them.
Charlie Weller, head of vaccines at the Wellcome Trust global heath charity said the Merck shot had already saved “countless lives” in the country.
“Having this vaccine available under research conditions has been key in preventing the ongoing outbreak in the DRC spiraling into a repeat of the 2014-16 epidemic, where 11,000 people died,” she told Reuters.
Health authorities in Kinshasa said last week they planned to introduce an experimental second Ebola vaccine, developed by drugmaker Johnson & Johnson, in the country's eastern provinces in November.
The Ebola virus causes hemorrhagic fever and spreads from person to person through direct contact with body fluids. It kills around half of those it infects.
There are currently no licensed treatments for the deadly infection, but scientists said in August they were a step closer to being able to cure it after two experimental drugs showed survival rates of as much as 90% in a clinical trial in Congo.


Clic here to read the story from its source.